Insider · CIK 0001892421
Wong Sing Ee Doris
Files at BGMS (Cyclacel Pharmaceuticals, Inc.), GTI (GRAPHJET TECHNOLOGY). First filing Nov 26, 2024, latest Dec 12, 2024.
In brief
Wong Sing Ee Doris files SEC Form 4 as director, CEO and 10% owner at GTI (GRAPHJET TECHNOLOGY), and also at BGMS (Cyclacel Pharmaceuticals, Inc.). Since Nov 26, 2024, Wong Sing Ee Doris has reported 0 open-market buys worth $0 and 5 open-market sells worth $2.8M, the latest filed on Dec 12, 2024.
A track record needs three past buys with six months of prices behind them; Wong Sing Ee Doris has 0, so none is measured yet.
The newest scored trade: sold $649k of GTI on Dec 12, 2024, filed Dec 12, 2024, scored 70 (notable).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 70Notable | GRAPHJET TECHNOLOGY | $649k 579,900 shares | -100% | - | |
| 75Notable | GRAPHJET TECHNOLOGY | $1.3M 600,000 shares | -51% | - | |
| 53Moderate | GRAPHJET TECHNOLOGY | $524k 165,591 shares | -12% | - | |
| 44Moderate | GRAPHJET TECHNOLOGY | $281k 100,000 shares | -7% | - | |
| 39Weak | GRAPHJET TECHNOLOGY | $85k 30,000 shares | -2% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | BGMS Cyclacel Pharmaceuticals, Inc. | AGrant or award Common Stock | +300,178 | $1.40 | $420k | 1,111,131 | Nov 13, 2025 |
| Dec 12, 2024 | GTI GRAPHJET TECHNOLOGY | SOpen-market sale Class A Ordinary Shares | -579,900 | $1.12 | $649k | 0 | Dec 12, 2024 |
| Dec 9, 2024 | GTI GRAPHJET TECHNOLOGY | SOpen-market sale Class A Ordinary Shares | -600,000 | $2.17 | $1.3M | 579,900 | Dec 10, 2024 |
| Dec 4, 2024 | GTI GRAPHJET TECHNOLOGY | SOpen-market sale Class A Ordinary Shares | -165,591 | $3.16 | $524k | 1,179,900 | Dec 6, 2024 |
| Dec 2, 2024 | GTI GRAPHJET TECHNOLOGY | SOpen-market sale Class A Ordinary Shares | -100,000 | $2.81 | $281k | 1,345,491 | Dec 3, 2024 |
| Nov 25, 2024 | GTI GRAPHJET TECHNOLOGY | SOpen-market sale Class A Ordinary Shares | -30,000 | $2.85 | $85k | 1,445,491 | Nov 26, 2024 |
Questions about Wong Sing Ee Doris
Answered from the filings on this page, as of the latest one.
Is Wong Sing Ee Doris buying or selling?
Not in the last 12 months. Wong Sing Ee Doris's latest open-market trade on SEC Form 4 was sold $649k of GTI on Dec 12, 2024.
How did Wong Sing Ee Doris's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wong Sing Ee Doris has 0.
Where does Wong Sing Ee Doris file Form 4?
Wong Sing Ee Doris has filed Form 4 at GTI (GRAPHJET TECHNOLOGY); BGMS (Cyclacel Pharmaceuticals, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.